This research aims to evaluate how advanced practice clinicians impact drug spending in dermatology using Medicare data.
Utilized Medicare Part D data for analysis
Focused on specialty medications in dermatology
Conducted an economic evaluation of spending trends
Found a significant association between advanced practice clinicians and drug spending trends
Showed variations in specialty medication costs linked to clinician involvement
Abstract
This economic evaluation study uses Medicare Part D data to assess the association between advanced practice clinicians and drug spending trends in dermatology, with a focus on specialty medications.